Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification...

Human Somatic Mutation Database (HSMD) 2.1.1 is now available, bringing 201,000+ new alterations with it. We are pleased to announce...

Dentro de las aplicaciones oncológicas, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer...

Dentro das aplicações oncológicas, a habilidade de identificar alterações genéticas potencialmente acionáveis e explorar as vulnerabilidades moleculares do câncer está...

Across clinical oncology applications, from molecular testing to cancer research, the ability to identify potentially actionable genomic and genetic alterations...

A new balancing act: How do clinical cancer geneticists and genetic counselors manage more patients with less time? The COVID-19...

In oncology research, identifying potentially actionable gene alterations and exploiting cancer’s molecular vulnerabilities is becoming increasingly difficult. Due to the...

The latest version of the Human Somatic Mutation Database (HSMD) is now available. HSMD 2.0 includes over 140,000 new alterations,...

Experts forecast this year’s cancer research advances In cancer research, the focus has shifted to precision medicine and much progress...